can glp-1 and dpp4 be used together Role of DPP-4 Inhibitors in Clinical Practice Insight into Structure Activity Relationship
Description
GLP-1 therapies reduce inflammation across organs through rapid, weight-independent immune and metabolic effects.
Substancj czynn zawart w leku jest semaglutyd, ktry zalicza si do grupy agonistw receptora GLP-1
In the presence of a mixture of gabazine (20 M) and tetrodotoxin (1 M), application GLP-1 significantly increased frequency, but not amplitude of miniature EPSCs via PKA signaling pathway
